Results 91 to 100 of about 11,568,194 (143)

Reduced diffusion associated with amyloid-related imaging abnormalities in three patients treated with donanemab. [PDF]

Neurocase
Schwartz NU, Dietz CD, Lin Z, Tammewar G, Bui N, La Joie R, Wang Y, Sreekrishnan A, Suhami D, VandeVrede L, Ljubenkov PA, Rojas JC.   +11 more
europepmc   +1 more source

Evaluation of plasma neurofilament and glial fibrillary acidic protein to predict or detect amyloid related imaging abnormalities. [PDF]

Alzheimers Dement (Amst)
Schwartz NU, Ellingson T, Nguyen H, Lin Z, Ashton NJ, Dage JL, Deniz K, Dietz CD, Ljubenkov PA, Miller BL, Nael K, Possin K, Rojas JC, Rosen HJ, Saloner R, Soleimani-Meigooni DN, Staffaroni AM, Stephens ML, Tammewar G, Wang Y, La Joie R, Rabinovici GD, Boxer AL, VandeVrede L.   +23 more
europepmc   +1 more source

A Severe Symptomatic Case of Amyloid-Related Imaging Abnormalities After Donanemab Infusion. [PDF]

Cureus
Harikumar N, Gupta M, Al Janabi T, Mand KK.   +3 more
europepmc   +1 more source

Amyloid-related imaging abnormalities after immunotherapy: How might brain microvascular basement membrane components be involved? [PDF]

J Alzheimers Dis
Vinters HV, Magaki S.
europepmc   +1 more source

Donanemab Infusion and Recurrent Seizures in a Patient With Alzheimer's Disease and Epilepsy in the Absence of Amyloid-Related Imaging Abnormalities (ARIA). [PDF]

Cureus
Espinosa PS, Li S, Preisler J, Hennekens CH.   +3 more
europepmc   +1 more source

Artificial Intelligence-Assisted Detection of Amyloid-Related Imaging Abnormalities: Promise and Pitfalls. [PDF]

AJNR Am J Neuroradiol
Petrella JR, Liu AJ, Wang LA, Doraiswamy PM.   +3 more
europepmc   +1 more source

Correction: Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data. [PDF]

Alzheimers Res Ther
Noguchi-Shinohara M, Yoshinobu T, Ozaki T, Muramatsu D, Shima A, Sakashita Y, Tada Y, Yamaguchi H, Komatsu J, Ikeda T, Ono K.   +10 more
europepmc   +1 more source

Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's disease treated with Lecanemab: A real-world study. [PDF]

J Prev Alzheimers Dis
Shimasaki R, Kurihara M, Bannai T, Hatano K, Suzuki F, Tokumaru AM, Ishii K, Ihara R, Iwata A.   +8 more
europepmc   +1 more source

Amyloid-related imaging abnormalities (ARIA) in Alzheimer's immunotherapy: a framework and challenges for global surveillance strategies. [PDF]

J Neurol Neurosurg Psychiatry
Hu N, Yang X, Feng F, Zhang B, Liu Y, Gao H, Chen Q, Zhang CJ, Chen X, Yan F, Haller S, Lui S.   +11 more
europepmc   +1 more source

Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup. [PDF]

Alzheimers Dement
van Etten ES, Mahinrad S, Grill JD, Salloway S, Atri A, Cogswell PM, Benzinger TLS, Iwatsubo T, Iadecola C, Lemere CA, Nicoll JAR, Greenberg SM, Carrillo MC, Jack CR, Sperling RA.   +14 more
europepmc   +1 more source